机构:
SBI Biotech Co Ltd, Dept Res & Dev, Ginko Biomed Res Inst, Kawasaki, Kanagawa, JapanTokyo Metropolitan Inst Med Sci, Genome Dynam Project, Bunkyo Ku, Tokyo 1138613, Japan
Ito, Sayuri
[2
]
Taniyami, Chika
论文数: 0引用数: 0
h-index: 0
机构:
SBI Biotech Co Ltd, Dept Res & Dev, Ginko Biomed Res Inst, Kawasaki, Kanagawa, JapanTokyo Metropolitan Inst Med Sci, Genome Dynam Project, Bunkyo Ku, Tokyo 1138613, Japan
Taniyami, Chika
[2
]
Arai, Naoko
论文数: 0引用数: 0
h-index: 0
机构:Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Bunkyo Ku, Tokyo 1138613, Japan
Arai, Naoko
Masai, Hisao
论文数: 0引用数: 0
h-index: 0
机构:
Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Bunkyo Ku, Tokyo 1138613, JapanTokyo Metropolitan Inst Med Sci, Genome Dynam Project, Bunkyo Ku, Tokyo 1138613, Japan
Masai, Hisao
[1
]
机构:
[1] Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Bunkyo Ku, Tokyo 1138613, Japan
[2] SBI Biotech Co Ltd, Dept Res & Dev, Ginko Biomed Res Inst, Kawasaki, Kanagawa, Japan
Cdc7 kinase plays crucial roles in firing of replication origins and in proper maintenance of replication forks, which are the sites of DNA replication. The inactivation of Cdc7 causes destabilization of replication forks leading to acute genomic instability and induces massive cell death preferentially in cancer cells. Thus, Cdc7 kinase may be a promising novel target for cancer therapy. Indeed, the first classes of Cdc7 inhibitors have been reported and have been shown to be effective in delaying tumor growth in animal models.